NS: Antidepressant drugs Flashcards
Which are the antidepressants of choice?
SSRIs are better tolerated and are safer in overdose than other classes of antidepressants and should be considered first-line for treating depression.
What antidepressant can be used in patients with unstable angina or recent MI?
Sertraline
Tricyclic antidepressants have similar efficacy to SSRI’s but more what?
side effects, more likely for treatment to be discontinued due to side effects than SSRIs
What benefits do SSRIs have over TCAs?
Tricyclic antidepressants have similar efficacy to SSRIs but are more likely to be discontinued because of side-effects; toxicity in overdosage is also a problem. SSRIs are less sedating and have fewer antimuscarinic and cardiotoxic effects than tricyclic antidepressants.
Why should MAOIs be reserved for use by specialists?
MAOIs have dangerous interactions with some foods and drugs, and should be reserved for use by specialists.
How frequently should patients be reviewed at the start of antidepressant treatment?
1-2 weeks.
Treatment should be continued for at least how long with antidepressants before considering whether to switch antidepressant due to lack of efficacy?
4 weeks (6 weeks in the elderly)
In cases of a partial response to antidepressant treatment, how long should treatment be continued for before completely ruling it out?
a further 2-4 weeks (elderly patients may take longer to reply)
Following remission, antidepressant treatment should be continued at the same dose for at least how long?
6 months (about 12 months in the elderly), or at least 12 months in patients receiving treatment for generalised anxiety disorder (as the likelihood of relapse is high).
Following remission, how long should patients with a history of recurrent depression receive maintenance treatment?
At least 2 years.
Hyponatraemia (usually in the elderly and possibly due to inappropriate secretion of antidiuretic hormone) has been associated with all types of antidepressants, what type most frequent?
SSRIs.
Hyponatraemia should be considered in all patients who develop drowsiness, confusion, or convulsions while taking an antidepressant.
What are the symptoms of hyponatraemia? (3)
Drowsiness
Confusion
Convulsions
Severe serotonin syndrome toxicity is a medical emergency which usually occurs with a combination of serotonergic drugs, one of which is generally what?
An MAOI.
The characteristic symptoms of serotonin syndrome fall into 3 main areas. What are these?
Neuromuscular hyperactivity: tremor, hyperreflexia, clonus, myoclonus, rigidity.
Autonomic dysfunction: tachycardia, blood pressure changes, hyperthermia, diaphoresis, shivering, diarrhoea.
Altered mental state: agitation, confusion, mania.
Failure to respond to initial treatment with an SSRI can be treated how? (3)
Increase the dose
Switch to a different SSRI
Switch to mirtazapine.
What are the second-line choices for treatment of depression after the failure of SSRIs or mirtazapine alone? (3)
Lofepramine: TCA
Moclobemide: reversible MOA inhibitor
Reboxetine: Inhibitor of norepinephrine reuptake (NRI)
When should TCAs (other than Lofepramine) and venlafaxine be considered in the treatment for depression?
Failure to respond to initial treatment with an SSRI may require an increase in the dose, or switching to a different SSRI or mirtazapine. Other second-line choices include lofepramine, moclobemide, and reboxetine. Other tricyclic antidepressants and venlafaxine should be considered for more severe forms of depression; irreversible MAOIs should only be prescribed by specialists.
Failure to respond to a second antidepressant may require the addition of another antidepressant of a different class, or use of an augmenting agent (such as what? 5 options, which of these are licensed?)
- Lithium - licensed.
- Aripiprazole - unlicensed.
- Olanzapine - unlicensed.
- Quetiapine - licensed.
- Risperidone - unlicensed.
Management of acute anxiety generally involves the use of what?
Benzodiazepine or buspirone hydrochloride: Selective serotonin subtype 1A (5-HT1A) partial agonist, with activity at both presynaptic and postsynaptic 5-HT1A receptors.